PA
MEDP icon

Procyon Advisors’s Medpace MEDP Stock Holding History

Procyon Advisors’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$373K Sell
705
-58
-8% -$26.8K 0.02% 411
2026
Q1 		$366K Hold
763
– – 0.02% 412
2025
Q4 		$429K Sell
763
-28
-4% -$15.9K 0.02% 358
2025
Q3 		$407K Buy
791
+1
+0.1% +$437 0.02% 346
2025
Q2 		$248K Sell
790
-28
-3% -$8.41K 0.02% 409
2025
Q1 		$249K Sell
818
-10
-1% -$3.36K 0.02% 517
2024
Q4 		$275K Sell
828
-125
-13% -$42.4K 0.02% 456
2024
Q3 		$318K Sell
953
-45
-5% -$17.1K 0.02% 438
2024
Q2 		$411K Sell
998
-692
-41% -$274K 0.03% 349
2024
Q1 		$683K Sell
1,690
-698
-29% -$245K 0.05% 274
2023
Q4 		$732K Buy
2,388
+252
+12% +$68K 0.06% 252
2023
Q3 		$517K Buy
2,136
+990
+86% +$253K 0.05% 294
2023
Q2 		$275K Sell
1,146
-161
-12% -$33.4K 0.03% 371
2023
Q1 		$246K Buy
1,307
+72
+6% +$14.9K 0.04% 337
2022
Q4 		$262K Buy
+1,235
New +$247K 0.05% 313
2022
Q3 		– Sell
-1,375
Closed -$206K – 326
2022
Q2 		$206K Buy
1,375
+73
+6% +$10.6K 0.05% 302
2022
Q1 		$213K Buy
+1,302
New +$215K 0.04% 311

Other funds holding MEDP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Procyon Advisors's MEDP Position: Q2 2026 in Review

Procyon Advisors reduced its Medpace (MEDP) stake by 7.6% in Q2 2026, selling an estimated $26.8K and leaving 705 shares worth $373K. The position accounts for 0.02% of the portfolio, ranked #411.

Procyon Advisors first reported a position in MEDP in Q1 2022 and has held it in 17 quarters since. The position peaked at $732K in Q4 2023. 695 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Procyon Advisors held 705 shares of Medpace worth $373K as of Q2 2026.
  • Procyon Advisors sold 58 Medpace shares in Q2 2026, an estimated $26.8K.
  • Medpace made up 0.02% of Procyon Advisors's portfolio in Q2 2026, its #411 holding.
  • Procyon Advisors first reported a position in Medpace in Q1 2022 and has held it in 17 quarters since.
  • Procyon Advisors's Medpace position peaked at $732K in Q4 2023.
  • 695 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Procyon Advisors's 13F filing for Q2 2026, filed 9 Jul 2026.